Levels of inhibitors of tumor necrosis factor alpha and interleukin 1β in urine and sera of patients with urosepsis

Infection and Immunity

Volumn 66, Issue 8, 1998, Pages 3527-3534

  Olszyna, Dariusz P ^a,b   Prins, Jan M ^a   Buis, Barbara ^a   Van Deventer, Sander J H ^a   Speelman, Peter ^a   Van Der Poll, Tom ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; PRIORITY JOURNAL; SEPSIS; URINARY TRACT INFECTION;

EID: 0031848169     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.8.3527-3534.1998     Document Type: Article

References (34)

1. Aderka, D., H. Engelmann, Y. Maor, C. Brakebusch, and D. Wallach. 1992. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J. Exp. Med. 175:323-329.
2. Agace, W., S. Hedges, M. Ceska, and C. Svanborg. 1993. Interleukin-8 and the neutrophil response to mucosal gram-negative infection. J. Clin. Invest. 92:780-785.
3. Bemelman, F. J., J. Jansen, T. van der Poll, S. J. H. van Deventer, and R. J. M. ten Berge. 1994. Increase of sTNF receptor levels in acute renal allograft rejection after treatment with OKT3. Nephrol. Dial. Transplant. 9:1786-1790.
4. Benson, M., U. Jodal, W. Agace, et al. 1996. Interleukin (IL)-6 and IL-8 in children with febrile urinary tract infection and asympotmatic bacteriuria. J. Infect. Dis. 174:1080-1084.
5. Benson, M., U. Jodal, A. Andreasson, A. Karlsson, J. Rydberg, and C. Svanborg. 1994. Interleukin 6 response to urinary tract infection in childhood. Pediatr. Infect. Dis. J. 13:612-616.
6. Bone, R. C., C. J. Grodzin, and R. A. Balk. 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112:235-243.
7. Brockhaus, M., Y. Bar-Khayim, S. Gurwicz, A. Frensdorff, and N. Hara. 1992. Plasma tumor necrosis factor soluble receptors in chronic renal failure. Kidney Int. 42:663-667.
8. Cassatella, M. A., L. Meda, S. Gasperini, F. Calzetti, and S. Bonora. 1994. Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J. Exp. Med. 179:1695-1699.
9. Davidoff, R., R. Yamaguchi, G. E. Leach, E. Park, and P. M. Lad. 1997. Multiple urinary cytokine levels of bacterial cystitis. J. Urol. 157:1980-1985.
10. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
11. Engelberts, I., S. Stephens, G. J. M. Francot, C. J. van der Linden, and W. A. Buurman. 1991. Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338:515-516.
12. Engelmann, H., M. Rubinstein, D. Rotman, and D. Wallach. 1989. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J. Biol. Chem. 264:11974-11980.
13. Ertel, W., F. A. Scholl, H. Gallati, M. Bonaccio, F. W. Schildberg, and O. Trentz. 1994. Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis. Arch. Surg. 129:1330-1336.
14. Fischer, E., K. J. Van Zee, M. Marano, et al. 1992. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196-2200.
15. Giri, J. G., J. Wells, and S. K. Dower, et al. 1994. Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J. Immunol. 153:5802-5809.
16. Hedges, S., P. Anderson, G. Lidin-Janson, P. de Man, and C. Svanborg. 1991. Interleukin-6 response to deliberate colonization of the human urinary tract with gram-negative bacteria. Infect. Immun. 59:421-427.
17. Hedges, S., K. Stenqvist, G. Lindin-Janson, J. Martinell, T. Sandberg, and C. Svanborg. 1992. Comparison of urine and serum concentrations of interleukin-6 in women with acute pyelonephritis or asymptomatic bacteriuria. J. Infect. Dis. 166:653-656.
18. Ko, Y., N. Mukaida, S. Ishiyama, et al. 1993. Elevated interleukin-8 levels in the urine of patients with urinary tract infections. Infect. Immun. 61:1307-1314.
19. Leeuwenberg, J. F. M., T. M. A. A. Jeunhomme, and W. A. Buurman. 1994. Slow release of TNF receptors by monocytes in vitro. J. Immunol. 152:4036-4040.
20. Marchant, A., J. Deviere, B. Byl, D. de Groote, J. L. Vincent, and M. Goldman. 1994. Interleukin-10 production during septicaemia. Lancet 343: 707-708.
21. Martins, S. M., D. J. Darlin, P. M. Lad, and P. E. Zimmern. 1994. Interleukin-1β: a clinically relevant urinary marker. J. Urol. 151:1198-1201.
22. Moore, K. W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T. R. Mosmann. 1993. Interleukin 10. Annu. Rev. Immunol. 11:165-190.
23. Olsson, I., M. Lantz, and E. Nilsson, et al. 1989. Isolation and characterization of a tumor necrosis factor binding protein from urine. Eur. J. Haematol. 42:270-275.
24. Prins, J. M., M. A. Van Agtmael, E. J. Kuijper, S. J. H. Van Deventer, and P. Speelman. 1995. Antibiotic induced endotoxin release in patients with gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J. Infect. Dis. 172:886-891.
25. Pruitt, J. H., M. B. Welborn, P. D. Edwards, et al. 1996. Increased soluble interleukin 1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87:3282-3288.
26. Rugo, H. S., P. O'Hanley, A. G. Bishop, et al. 1992. Local cytokine production in a murine model of Escherichia coli pyelonephritis. J. Clin. Invest. 89:1032-1039.
27. Seckinger, P., S. Isaaz, and J. M. Dayer. 1989. Purification and biologic characterization of a specific tumor necrosis factor α inhibitor. J. Biol. Chem. 264:11966-11973.
28. Sims, J. E., J. G. Giri, and S. K. Dower. 1994. The two interleukin-1 receptors play different roles in IL-1 actions. Clin. Immunol. Immunopathol. 72:9-14.
29. Svanborg, C. 1993. Resistance to urinary tract infection. N. Engl. J. Med. 329:802-803.
30. Van der Poll, T., J. Jansen, D. van Leenen, et al. 1993. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J. Infect. Dis. 168:955-960.
31. Van der Poll, T., and S. F. Lowry. 1995. Endogenous mechanisms regulating TNF and IL-1 during sepsis, p. 385-397. In J. L. Vincent (ed.), Year-book of intensive care and emergency medicine. Springer-Verlag, New York.
32. Van der Poll, T., and S. F. Lowry. 1995. Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defense? Shock 3:1-12.
33. Van der Poll, T., R. de Waal Malefyt, S. M. Coyle, and S. F. Lowry. 1997. Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10 and IL-13 concentrations. J. Infect. Dis. 175:118-122.
34. Van Zee, K. J., T. Kohno, E. Fischer, S. C. Rock, L. L. Moldawer, and S. F. Lowry. 1992. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor α in vitro and in vivo. Proc. Natl. Acad. Sci. USA 89:4845-4849.